Related Experiment Video
Updated: Aug 6, 2025
10:10
Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds
Published on: November 13, 2021
8.2K
Cholesteric liquid crystal biosensor platform with image analysis for rapid detection of COVID-19
Ping-Yuan Lin1, Yi-Wei Chung2,3,4,5, Er-Yuan Chuang6
1Graduate Institute of Biomedical Opto mechatronics, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
Frontiers in Bioengineering and Biotechnology
|March 17, 2023
Summary
A novel cholesteric liquid crystal biosensor offers rapid, wash-free detection of SARS-CoV-2, addressing limitations of current COVID-19 diagnostic tests. This innovation aims to improve early identification and control of the virus spread.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Infectious Disease Diagnostics
Background:
- Accurate and rapid diagnosis of COVID-19 is crucial for controlling disease transmission, especially for asymptomatic carriers.
- Current diagnostic methods like RT-PCR can be time-consuming, while antibody tests have limitations such as high false positive rates.
- There is a need for innovative diagnostic platforms that are fast, cost-effective, and reliable.
Purpose of the Study:
- To develop and validate a novel cholesteric liquid crystal (CLC) biosensor for the direct detection of SARS-CoV-2.
- To evaluate the CLC biosensor's performance as a rapid, one-step, and wash-free diagnostic tool for COVID-19.
- To demonstrate the potential of CLC technology for point-of-care diagnostics in infectious diseases.
Main Methods:
- Utilized a cholesteric liquid crystal (CLC) biosensor platform for direct virus detection.
- Implemented a one-step, wash-free assay requiring minimal sample pre-processing.
- Focused on detecting the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) directly.
Main Results:
- The CLC biosensor platform enables rapid detection of SARS-CoV-2.
- The proposed method is a one-step, wash-free process, simplifying diagnostic procedures.
- Minimal sample pre-processing is required, enhancing usability for rapid testing.
Conclusions:
- Cholesteric liquid crystals provide an effective and innovative approach for rapid COVID-19 diagnosis.
- The developed CLC biosensor shows promise as a valuable tool for early detection and management of SARS-CoV-2 infections.
- This technology has broader implications for developing rapid diagnostic tests for various diseases.
